GLMD logo

Galmed Pharmaceuticals (GLMD) Current Liabilities

Annual Current Liabilities

$2.75 M
-$344.00 K-11.12%

31 December 2023

GLMD Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Liabilities

$2.51 M
+$960.00 K+61.78%

30 September 2024

GLMD Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

GLMD Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-11.1%+20.2%
3 y3 years-65.7%-60.4%
5 y5 years+1.6%-29.0%

GLMD Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-65.7%at low-60.4%+61.8%
5 y5 years-65.7%+1.6%-68.6%+61.8%
alltimeall time-65.7%+436.1%-68.6%+262.3%

Galmed Pharmaceuticals Current Liabilities History

DateAnnualQuarterly
Sept 2024
-
$2.51 M(+61.8%)
June 2024
-
$1.55 M(-12.0%)
Mar 2024
-
$1.76 M(-35.8%)
Dec 2023
$2.75 M(-11.1%)
$2.75 M(+31.5%)
Sept 2023
-
$2.09 M(-23.2%)
June 2023
-
$2.72 M(-2.8%)
Mar 2023
-
$2.80 M(-9.5%)
Dec 2022
$3.09 M(-47.4%)
$3.09 M(-38.5%)
Sept 2022
-
$5.03 M(+84.4%)
June 2022
-
$2.73 M(-51.7%)
Mar 2022
-
$5.65 M(-3.9%)
Dec 2021
$5.88 M(-26.6%)
$5.88 M(-7.4%)
Sept 2021
-
$6.35 M(-9.4%)
June 2021
-
$7.01 M(-1.8%)
Mar 2021
-
$7.14 M(-10.9%)
Dec 2020
$8.01 M(+15.5%)
$8.01 M(+32.4%)
Sept 2020
-
$6.05 M(+28.3%)
June 2020
-
$4.71 M(-21.9%)
Mar 2020
-
$6.03 M(-13.0%)
Dec 2019
$6.93 M
$6.93 M(+95.9%)
Sept 2019
-
$3.54 M(+7.9%)
June 2019
-
$3.28 M(+36.2%)
DateAnnualQuarterly
Mar 2019
-
$2.41 M(-11.0%)
Dec 2018
$2.71 M(-29.7%)
$2.71 M(+26.5%)
Sept 2018
-
$2.14 M(-43.8%)
June 2018
-
$3.80 M(+41.0%)
Mar 2018
-
$2.70 M(-29.9%)
Dec 2017
$3.85 M(-16.0%)
$3.85 M(+28.5%)
Sept 2017
-
$3.00 M(-17.6%)
June 2017
-
$3.63 M(-4.8%)
Mar 2017
-
$3.82 M(-16.6%)
Dec 2016
$4.58 M(+80.2%)
$4.58 M(+60.1%)
Sept 2016
-
$2.86 M(-14.7%)
June 2016
-
$3.35 M(+10.9%)
Mar 2016
-
$3.02 M(+19.0%)
Dec 2015
$2.54 M(+127.3%)
$2.54 M(+91.6%)
Sept 2015
-
$1.33 M(-11.7%)
June 2015
-
$1.50 M(+10.7%)
Mar 2015
-
$1.36 M(+21.3%)
Dec 2014
$1.12 M(-33.8%)
$1.12 M(-56.4%)
Sept 2014
-
$2.56 M(+269.6%)
June 2014
-
$694.00 K(-53.7%)
Mar 2014
-
$1.50 M(-11.3%)
Dec 2013
$1.69 M(+229.2%)
$1.69 M
Dec 2012
$513.00 K
-

FAQ

  • What is Galmed Pharmaceuticals annual total current liabilities?
  • What is the all time high annual current liabilities for Galmed Pharmaceuticals?
  • What is Galmed Pharmaceuticals annual current liabilities year-on-year change?
  • What is Galmed Pharmaceuticals quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Galmed Pharmaceuticals?
  • What is Galmed Pharmaceuticals quarterly current liabilities year-on-year change?

What is Galmed Pharmaceuticals annual total current liabilities?

The current annual current liabilities of GLMD is $2.75 M

What is the all time high annual current liabilities for Galmed Pharmaceuticals?

Galmed Pharmaceuticals all-time high annual total current liabilities is $8.01 M

What is Galmed Pharmaceuticals annual current liabilities year-on-year change?

Over the past year, GLMD annual total current liabilities has changed by -$344.00 K (-11.12%)

What is Galmed Pharmaceuticals quarterly total current liabilities?

The current quarterly current liabilities of GLMD is $2.51 M

What is the all time high quarterly current liabilities for Galmed Pharmaceuticals?

Galmed Pharmaceuticals all-time high quarterly total current liabilities is $8.01 M

What is Galmed Pharmaceuticals quarterly current liabilities year-on-year change?

Over the past year, GLMD quarterly total current liabilities has changed by +$423.00 K (+20.23%)